5.91
前日終値:
$6.09
開ける:
$6.17
24時間の取引高:
37,961
Relative Volume:
0.14
時価総額:
$224.80M
収益:
$239.40M
当期純損益:
$104.44M
株価収益率:
1.9966
EPS:
2.96
ネットキャッシュフロー:
$-18.50M
1週間 パフォーマンス:
-0.17%
1か月 パフォーマンス:
+11.93%
6か月 パフォーマンス:
-25.19%
1年 パフォーマンス:
-64.78%
Entrada Therapeutics Inc Stock (TRDA) Company Profile
名前
Entrada Therapeutics Inc
セクター
電話
857-305-1825
住所
ONE DESIGN CENTER PLACE, BOSTON
TRDA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TRDA
Entrada Therapeutics Inc
|
5.91 | 231.65M | 239.40M | 104.44M | -18.50M | 2.96 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-06 | 開始されました | ROTH MKM | Buy |
2024-01-05 | 開始されました | Oppenheimer | Outperform |
2023-04-03 | 開始されました | H.C. Wainwright | Buy |
Entrada Therapeutics Inc (TRDA) 最新ニュース
Technical analysis overview for Entrada Therapeutics Inc. stockEarnings Overview Report & Real-Time Buy Zone Alerts - newser.com
Applying sector rotation models to Entrada Therapeutics Inc.July 2025 Highlights & Fast Entry High Yield Tips - newser.com
Best data tools to analyze Entrada Therapeutics Inc. stockJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Sector ETF performance correlation with Entrada Therapeutics Inc.2025 Trading Recap & Consistent Growth Stock Picks - newser.com
Is it time to cut losses on Entrada Therapeutics Inc.July 2025 Opening Moves & Consistent Income Trade Ideas - newser.com
Signal strength of Entrada Therapeutics Inc. stock in tech scanners2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com
Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st
Entrada Therapeutics (NASDAQ:TRDA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
H.C. Wainwright maintains $20 target on Entrada Therapeutics stock - MSN
Analysts Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Target Price at $25.67 - Defense World
What’s next for Entrada Therapeutics Inc. stock priceStop Loss & Weekly Sector Rotation Insights - newser.com
What high frequency data says about Entrada Therapeutics Inc.Weekly Trend Report & Daily Chart Pattern Signals - newser.com
How to forecast Entrada Therapeutics Inc. trends using time series2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Can swing trading help recover from Entrada Therapeutics Inc. lossesTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com
Statistical indicators supporting Entrada Therapeutics Inc.’s strengthMarket Trend Summary & Growth Focused Entry Reports - newser.com
Why Entrada Therapeutics Inc. stock is in analyst buy zone2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Entrada Therapeutics Inc Stock Analysis and ForecastMarket Rumors and News & Free Trading Psychology Coaching - earlytimes.in
What analysts say about Entrada Therapeutics Inc stockStochastic Oscillator Alerts & Exceptional Capital Trading - earlytimes.in
How Regulatory Changes Could Impact JITF Infralogistics Limited’s BusinessSector Performance Review & Buy Sell Signal Notifications - earlytimes.in
Should you hold or exit Entrada Therapeutics Inc. nowCEO Change & Fast Momentum Stock Entry Tips - newser.com
What drives Entrada Therapeutics Inc stock priceShort Interest Overview & Connect With Bulls, Avoid the Bears - Early Times
Is Entrada Therapeutics Inc. stock a top momentum playJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - The British Mountaineering Council
Transcript : Entrada Therapeutics, Inc.Special Call - MarketScreener
Using Ichimoku Cloud for Entrada Therapeutics Inc. technicalsQuarterly Earnings Summary & Reliable Momentum Entry Alerts - newser.com
Goldman Sachs Group Inc. Has $837,000 Stock Holdings in Entrada Therapeutics, Inc. $TRDA - Defense World
How institutional ownership impacts Entrada Therapeutics Inc. stockProfit Target & Accurate Intraday Trading Signals - newser.com
Strs Ohio Acquires New Shares in Entrada Therapeutics, Inc. $TRDA - Defense World
Entrada Therapeutics Inc (TRDA) 財務データ
収益
当期純利益
現金流量
EPS
Entrada Therapeutics Inc (TRDA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
5AM Ventures V, L.P. | 10% Owner |
Jul 09 '25 |
Sale |
7.50 |
20,065 |
150,528 |
3,163,066 |
5AM Ventures V, L.P. | 10% Owner |
Jul 09 '25 |
Sale |
7.50 |
6,935 |
52,026 |
1,093,313 |
大文字化:
|
ボリューム (24 時間):